Baker Bros. Advisors LP Madrigal Pharmaceuticals, Inc. Transaction History
Baker Bros. Advisors LP
- $7.9 Billion
- Q1 2024
A detailed history of Baker Bros. Advisors LP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 1,969,798 shares of MDGL stock, worth $465 Million. This represents 6.66% of its overall portfolio holdings.
Number of Shares
1,969,798
Previous 1,969,798
-0.0%
Holding current value
$465 Million
Previous $456 Million
15.41%
% of portfolio
6.66%
Previous 5.3%
Shares
7 transactions
Others Institutions Holding MDGL
# of Institutions
313Shares Held
20MCall Options Held
824KPut Options Held
1.04M-
Janus Henderson Group PLC London, X02.6MShares$614 Million0.39% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.94MShares$459 Million6.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.78MShares$419 Million34.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$394 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.21MShares$286 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.04B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...